We recently identified the heterozygous T125M (ACG to ATG) mutation of the TP53 gene (Figure 4A) in one of the BCP-ALL cell lines, MB-IT, which was established at diagnosis from a 10-year-old ALL patient [17]. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.